Introduction to Drug Development – From Candidate Selection to Patients in Healthcare

Those who want to understand what is done to bring new treatments to patients, and/or better operate with the language of internal customers. Typically people in non life-science technical roles in our sector – IT, Finance, HR and Admin staff. Also helpful for early research professionals who wish to broaden their knowledge of later stage development.

A one day course

This course generates understanding of the range of activities that take a new candidate drug molecule through Development, Manufacturing and Commercialization to routine patient use.  

The general industry structure (pharmaceutical, biotechnology and vaccines) background is also explored; who are the players, how big/small, how do they interact with each other and with various service organisations.

It is a highly interactive, clearly explained journey through:

- Technical development – making the molecule and the medicine

- Preclinical safety – ensuring drugs are safe enough for patient use

- Early clinical trials – evaluating viability of new drugs

- Integrating healthcare with digital support and advanced diagnostics

- Major trials and Regulatory – proving value and seeking license to market

- Branding and commercialization for launch

- Manufacturing and supply chain set up

- Getting new treatments to patients worldwide

One Nucleus Gold: £392 + VAT
One Nucleus Silver: £476 + VAT
Non-members: £560 + VAT